Topics

High-grade gliomas | Outcomes | Immunotherapy response

Home > Publications > Topics > High-grade gliomas > Outcomes > Immunotherapy response

Srinivasan S, Eraghi MM, Odiase P, Mazumder S, Ahuja A, Ranganathan S, Patel P, O'Leary S, Guirguis M, Barrie U, Sun MZ, Patel A.
Prognostic utility of tumor grade and IDH-mutation status for immunotherapy response in high grade glioma: a systematic review and meta-analysis.
J Clin Neurosci. 2026 Jul 20;152:112202. doi: 10.1016/j.jocn.2026.112202. PMID: 42475978. ˍ